The use of recombinant human activated protein C (drotrecogin alpha) in solid organ transplant recipients: case series and review of the literature. [electronic resource]
Producer: 20120417Description: 592-7 p. digitalISSN:- 1399-3062
- Adult
- Aged
- Anti-Infective Agents -- adverse effects
- Anti-Inflammatory Agents -- therapeutic use
- Anticoagulants -- therapeutic use
- Hemorrhage -- chemically induced
- Humans
- Immunosuppression Therapy -- adverse effects
- Middle Aged
- Organ Transplantation
- Postoperative Complications -- prevention & control
- Protein C -- adverse effects
- Recombinant Proteins -- adverse effects
- Retrospective Studies
- Shock, Septic -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.